Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis
Olivia G. Thomas, Mattias Bronge, Katarina Tengvall, et al.
Science Advances (2023) Vol. 9, Iss. 20
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis
Hannes Vietzen, S. Berger, Laura M. Kühner, et al.
Cell (2023) Vol. 186, Iss. 26, pp. 5705-5718.e13
Open Access | Times Cited: 78
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
Massimiliano Calabrese, Paolo Preziosa, Antonio Scalfari, et al.
Annals of Neurology (2024) Vol. 96, Iss. 1, pp. 1-20
Open Access | Times Cited: 27
Epstein–Barr virus as a potentiator of autoimmune diseases
William H. Robinson, Shady Younis, Zelda Z. Love, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 11, pp. 729-740
Closed Access | Times Cited: 16
Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis
Marianna Cortese, Yumei Leng, Kjetil Bjørnevik, et al.
JAMA Neurology (2024) Vol. 81, Iss. 5, pp. 515-515
Closed Access | Times Cited: 15
Molecular mimicry in multisystem inflammatory syndrome in children
Aaron Bodansky, Robert C. Mettelman, Joseph J. Sabatino, et al.
Nature (2024) Vol. 632, Iss. 8025, pp. 622-629
Open Access | Times Cited: 14
Codon-optimization in gene therapy: promises, prospects and challenges
Anastasiia Iu. Paremskaia, Anna A. Kogan, А. А. Мурашкина, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 11
Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis
Jesse Huang, Katarina Tengvall, Izaura Bomfim Lima, et al.
Brain (2024) Vol. 147, Iss. 10, pp. 3573-3582
Open Access | Times Cited: 9
Epidemiology of Multiple Sclerosis: Global, Regional, National and Sub-National-Level Estimates and Future Projections
Gulfaraz Khan, Muhammad Jawad Hashim
Journal of Epidemiology and Global Health (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Multiple Sclerosis
Joseph J. Sabatino, Lawrence Steinman
Neurology Neuroimmunology & Neuroinflammation (2025) Vol. 12, Iss. 2
Open Access | Times Cited: 1
Altered immune landscape of cervical lymph nodes reveals Epstein-Barr virus signature in multiple sclerosis
Joona Sarkkinen, Dawit Yohannes, Nea Kreivi, et al.
Science Immunology (2025) Vol. 10, Iss. 104
Closed Access | Times Cited: 1
4D marmoset brain map reveals MRI and molecular signatures for onset of multiple sclerosis–like lesions
Jing‐Ping Lin, Alexis Brake, Maxime Donadieu, et al.
Science (2025) Vol. 387, Iss. 6737
Closed Access | Times Cited: 1
Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls
Neda Sattarnezhad, Ingrid Kockum, Olivia G. Thomas, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 11
Open Access | Times Cited: 1
Epstein–Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism
Olivia G. Thomas, Alan B. Rickinson, Umaimainthan Palendira
Clinical & Translational Immunology (2023) Vol. 12, Iss. 5
Open Access | Times Cited: 18
Single cell sequencing revealed the mechanism of CRYAB in glioma and its diagnostic and prognostic value
Hua-Bao Cai, Meng-Yu Zhao, Xin-Han Li, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 5
EBV infected cells in the multiple sclerosis brain express PD-L1: How the virus and its niche may escape immune surveillance
Barbara Serafini, Lucia Benincasa, Barbara Rosicarelli, et al.
Journal of Neuroimmunology (2024) Vol. 389, pp. 578314-578314
Open Access | Times Cited: 5
Multiple sclerosis and infection: history, EBV, and the search for mechanism
Elliott D. SoRelle, Micah A. Luftig
Microbiology and Molecular Biology Reviews (2025)
Closed Access
Epstein–Barr virus and the immune microenvironment in multiple sclerosis: Insights from high-dimensional brain tissue imaging
Noga Or‐Geva, Lawrence Steinman
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 11
Open Access
Single-cell RNA sequencing reveals the heterogeneity and regulatory modules of cell-specific RNA-binding proteins in patients with systemic lupus erythematosus
Sheng‐Yan Lin, Yikai Yu, Daan Nie, et al.
Biochemistry and Biophysics Reports (2025) Vol. 42, pp. 101977-101977
Closed Access
Single nuclei RNAseq stratifies multiple sclerosis patients into distinct white matter glial responses
Will Macnair, Daniela Calini, Eneritz Agirre, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 20
Shift of the insoluble content of the proteome in the aging mouse brain
Cristen Molzahn, Erich R. Kuechler, Irina Zemlyankina, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 45
Open Access | Times Cited: 11
Altered EBV specific immune control in multiple sclerosis
Christian Münz
Journal of Neuroimmunology (2024) Vol. 390, pp. 578343-578343
Open Access | Times Cited: 4
Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation
Tilman Schneider‐Hohendorf, Christian Wünsch, Simon Falk, et al.
Brain (2024)
Closed Access | Times Cited: 4
Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach
Vivien Li, Fiona C. McKay, David C. Tscharke, et al.
CNS Drugs (2025)
Closed Access
Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators
Michael Hecker, Brit Fitzner, Isis Ludwig‐Portugall, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Emerging drugs for Epstein-Barr virus associated-diseases
Nassima Oumata, Qian Zhong, Yongmin Zhang, et al.
European Journal of Medicinal Chemistry (2025), pp. 117386-117386
Closed Access
Page 1 - Next Page

Scroll to top